Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

Reevaluating Eligibility Criteria — Balancing Patient Protection and Participation in Oncology Trials

(2017) Julia A. Beaver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents

(2016) Meredith K. Chuk et al.   CLINICAL CANCER RESEARCH

Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)

(2016) Vania Tacher et al.   EUROPEAN JOURNAL OF CANCER

Implementation of mechanism of action biology-driven early drug development for children with cancer

(2016) Andrew D.J. Pearson et al.   EUROPEAN JOURNAL OF CANCER

Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations

(2016) Lavinia Spain et al.   EXPERT OPINION ON PHARMACOTHERAPY

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

(2015) M. S. Merchant et al.   CLINICAL CANCER RESEARCH

Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer

(2015) Gilles Vassal et al.   EUROPEAN JOURNAL OF CANCER

Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project

(2015) D. Stark et al.   EUROPEAN JOURNAL OF CANCER CARE

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

(2015) Giles W. Robinson et al.   JOURNAL OF CLINICAL ONCOLOGY

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance

(2014) Alberto S. Pappo et al.   CANCER

Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

(2014) Marcel Kool et al.   CANCER CELL

Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials

(2014) Lorna A Fern et al.   LANCET ONCOLOGY

Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE® Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications

(2014) Lindsey M. Hoffman et al.   Frontiers in Oncology

A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trials

(2013) Xavier Paoletti et al.   EUROPEAN JOURNAL OF CANCER

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

(2013) Sant Chawla et al.   LANCET ONCOLOGY

Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007

(2013) Jeremiah D. Momper et al.   JAMA Pediatrics

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

(2011) S. G. DuBois et al.   CLINICAL CANCER RESEARCH

Population Analysis of Erlotinib in Adults and Children Reveals Pharmacokinetic Characteristics as the Main Factor Explaining Tolerance Particularities in Children

(2011) M. White-Koning et al.   CLINICAL CANCER RESEARCH

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors

(2011) P. M. LoRusso et al.   CLINICAL CANCER RESEARCH

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

(2011) M. A. Fanale et al.   CLINICAL CANCER RESEARCH

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia

(2010) Andrea Meinhardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Pharmacology in the Adolescent Oncology Patient

(2010) Gareth J. Veal et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

(2009) David Olmos et al.   LANCET ONCOLOGY